Medical cannabis to hypermobility-associated chronic pain relief

Added on 27 March 2025

Tags

Medical cannabis to hypermobility-associated chronic pain relief

Photo by Indorgro on Unsplash

A RECENT study conducted with the UK Medical Cannabis Registry evaluated the impact of cannabis-based medicinal products (CBMPs) on patients suffering from chronic pain due to hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).

The research, which focused on outcomes such as pain reduction and quality of life improvements, reveals promising results for these patients, suggesting cannabis could be an effective therapeutic option.